Download Citation
Article Source:
Targeting Wild-Type and Mutationally Activated FGFR4 in Rhabdomyosarcoma with the Inhibitor Ponatinib (AP24534)
Li SQ,
Cheuk AT,
Shern JF,
Song YK,
Hurd L,
et al.
(2013)
Targeting Wild-Type and Mutationally Activated FGFR4 in Rhabdomyosarcoma with the Inhibitor Ponatinib (AP24534).
PLOS ONE 8(10): e76551.
https://doi.org/10.1371/journal.pone.0076551